Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Oct 12;18(10):2129.
doi: 10.3390/ijms18102129.

Control of NK Cell Activation by Immune Checkpoint Molecules

Asma Beldi-Ferchiou  1 , Sophie Caillat-Zucman  2   3
Affiliations
Review

Control of NK Cell Activation by Immune Checkpoint Molecules

Asma Beldi-Ferchiou et al. Int J Mol Sci. .

Abstract

The development of cancer and chronic infections is facilitated by many subversion mechanisms, among which enhanced expression of immune checkpoints molecules, such as programmed death-1 (PD-1) and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), on exhausted T cells. Recently, immune checkpoint inhibitors have shown remarkable efficiency in the treatment of a number of cancers. However, expression of immune checkpoints on natural killer (NK) cells and its functional consequences on NK cell effector functions are much less explored. In this review, we focus on the current knowledge on expression of various immune checkpoints in NK cells, how it can alter NK cell-mediated cytotoxicity and cytokine production. Dissecting the role of these inhibitory mechanisms in NK cells is critical for the full understanding of the mode of action of immunotherapies using checkpoint inhibitors in the treatment of cancers and chronic infections.

Keywords: NK cells; cancer immunotherapy; immune checkpoint molecules.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S. Functions of natural killer cells. Nat. Immunol. 2008;9:503–510. doi: 10.1038/ni1582. - DOI - PubMed
    1. Lodoen M.B., Lanier L.L. Natural killer cells as an initial defense against pathogens. Curr. Opin. Immunol. 2006;18:391–398. doi: 10.1016/j.coi.2006.05.002. - DOI - PMC - PubMed
    1. Cerwenka A., Lanier L.L. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 2001;1:41–49. doi: 10.1038/35095564. - DOI - PubMed
    1. Sivori S., Carlomagno S., Pesce S., Moretta A., Vitale M., Marcenaro E. TLR/NCR/KIR: Which one to use and when? Front. Immunol. 2014;5 doi: 10.3389/fimmu.2014.00105. - DOI - PMC - PubMed
    1. Raulet D.H., Guerra N. Oncogenic stress sensed by the immune system: Role of natural killer cell receptors. Nat. Rev. Immunol. 2009;9:568–580. doi: 10.1038/nri2604. - DOI - PMC - PubMed

MeSH terms

Substances